Corporate Board Profile
Tech Score: 25/100
1 mention(s) identify AUGUSTINE CHOW, PH.D. as having software/technology expertise.
Company | Filing Date | Evidence | Reason |
---|---|---|---|
Imunon, Inc. | 2023-04-28 | Dr. Lindborg’s holds the position of co-Chief Executive Officer at Brainstorm Cell Therapeutics, which she joined in 2020. From 2012 to 2020 she held positions of increasing responsibility at Biogen, where she worked in biostatistics and biometrics, and served as Vice President for Global Analytics and Data Sciences. | Dr. Chow holds a Ph.D. and has extensive experience in biostatistics and biometrics, indicating strong technical and quantitative skills relevant to programming and software. |
Filing Date | Source Excerpt |
---|---|
2012-04-27 | Dr. Chow’s qualifications include a MSc from London Business School, a PhD in the Transfer of Technology from the University of South Australia, a DBA in Internet Research from Southern Cross University, and an Engineering Doctorate in the Commercialization of Radical Innovation. |
2013-06-07 | Dr. Chow’s qualifications include a number of Bachelors, Masters and Doctoral degrees. Among them include a MSc from London Business School, a Ph.D. in the Transfer of Technology from the University of South Australia, and an Engineering Doctorate and Ph.D. from City University of Hong Kong. |
2015-04-30 | Dr. Chow’s qualifications include a number of Bachelors, Masters and Doctoral degrees. Among them include a MSc from London Business School, a Ph.D. from the University of South Australia, and an Engineering Doctorate and Ph.D. on Biology from City University of Hong Kong. |
2023-04-28 | Dr. Lindborg’s holds the position of co-Chief Executive Officer at Brainstorm Cell Therapeutics, which she joined in 2020. From 2012 to 2020 she held positions of increasing responsibility at Biogen, where she worked in biostatistics and biometrics, and served as Vice President for Global Analytics and Data Sciences. |
Data sourced from SEC filings. Last updated: 2025-06-22